EE408 Embracing the Long-Term in Disruptive Health Innovations: A Strategic Necessity or a Necessary Evil? Cost Utility of Langerhans Islet Grafting in Unstable Type 1 Diabetes
Abstract
Authors
Sandra David-Tchouda Rosy Fares Hanane Kebaili Dimitri Sourd Thierry Berney Laurence Kessler Lionel Badet Jean-Pierre Riveline François Pattou Sandrine Lablanche Pierre-Yves Benhamou